Genetic and environmental influences on the ratio of 30hydroxycotinine to cotinine in plasma and urine

Gary E. Swan,Christina N Lessov-Schlaggar,Andrew W Bergen,Yungang He,Rachel F. Tyndale,Neal L. Benowitz
2009-01-01
Abstract:Methods One hundred and thirty-nine twin pairs [110 monozygotic and 29 dizygotic] underwent a 30-min infusion of stable isotope-labelled nicotine and its major metabolite, cotinine, followed by an 8-h in-hospital stay. Blood and urine samples were taken at regular intervals for analysis of nicotine, cotinine, and metabolites. DNA was genotyped to confirm zygosity and for variation in the gene for the primary nicotine metabolic enzyme, CYP2A6 (variants genotyped: *1B, *1 2, *2, *4, *9, *12). Univariate biometric analyses quantified genetic and environmental influences on each measure in the presence and absence of covariates, including measured CYP2A6 genotype.
What problem does this paper attempt to address?